Evidence map›Paper›PMID 31110198›Full record

ArticleScientific reports2019

A phase I clinical trial for [

Hiroshi Wakabayashi, Anri Inaki, Kenichi Yoshimura, Toshinori Murayama, Yasuhito Imai, Tetsuya Higuchi, Megumi Jinguji, Tohru Shiga, Seigo Kinuya

Erratum issuedOpen access · goldAbstract readClinical Trial, Phase I
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Drug metabolism and disposition: the biological fate of chemicals · 2022
    Article
  7. Review
  8. Metastatic Pheochromocytomas and Abdominal Paragangliomas.The Journal of clinical endocrinology and metabolism · 2021
    Review
  9. Recent advances in the management of pheochromocytoma and paraganglioma.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Hiroshi WakabayashiDepartment of Nuclear Medicine, Kanazawa University Hospital, Ishikawa, Japan. wakabayashi@staff.kanazawa-u.ac.jp.
Anri InakiDepartment of Nuclear Medicine, Kanazawa University Hospital, Ishikawa, Japan.ORCID http://orcid.org/0000-0003-1209-7164
Kenichi YoshimuraDepartment of Biostatistics, Innovative Clinical Research Center, Kanazawa University Hospital, Ishikawa, Japan.
Toshinori MurayamaDepartment of Clinical Development, Kanazawa University Hospital, Ishikawa, Japan.
Yasuhito ImaiDepartment of Data Center, Innovative Clinical Research Center, Kanazawa University Hospital, Ishikawa, Japan.
Tetsuya HiguchiDepartment of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Gunma, Japan.
Megumi JingujiDepartment of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Tohru ShigaDepartment of Nuclear Medicine, Hokkaido University, Hokkaido, Japan.
Seigo KinuyaDepartment of Nuclear Medicine, Kanazawa University Hospital, Ishikawa, Japan.
Kanazawa University Hospital · JPGunma University · JPHokkaido University · JPKagoshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Refractory pheochromocytoma and paraganglioma (PPGL) have a poor prognosis and the treatment strategy remains to be established. This multi-institutional phase I study was performed to determine the safety, dose-limiting toxicity (DLT), and efficacy of [

Indexed as

Adrenal Gland NeoplasmsAdultAgedAged, 80 and overFemaleHumansIodine RadioisotopesMaleMiddle AgedParagangliomaPheochromocytomaRadiopharmaceuticalsYoung AdultIodine RadioisotopesRadiopharmaceuticals

Identifiers

PMID31110198
PMCPMC6527850
OpenAlexW2945849252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.